Significant advances have been made over the last 20 years in long-term immunomodulatory therapy of multiple sclerosis. However, the same cannot be said for the treatment of acute relapses, explain ...

Dublin, Feb. 10, 2020 (GLOBE NEWSWIRE) -- The "Apheresis Market by Product [Device (Centrifugation, Membrane Separation) Disposable], Procedure (Donor, Therapeutic ...

ENGLEWOOD, Colo., Aug. 15, 2022 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain ...

LONDON--(BUSINESS WIRE)--The apheresis devices market is expected to grow by USD 812.44 million during 2020-2024, according to the latest market research report by Technavio, progressing at a CAGR of ...

Subhash Banerjee, MD (VA North Texas Health Care System & UT Southwestern Medical Center, Dallas), who presented the results of the PREMIER trial in a featured clinical research session at the annual ...

The growth of the therapeutic apheresis market is driven by rise in prevalence of chronic and autoimmune diseases, technological advancements in apheresis devices, and favorable government initiatives ...

DUBLIN--(BUSINESS WIRE)--The "Apheresis Equipment - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering. The report provides separate comprehensive ...

Apheresis for Leukemia and Pediatric Patients. Emerging Economies With Increasing Investments From Government Bodies and Leading Players. This study involved the extensive use of both primary and ...

Microplastics are particles ranging from 1 micrometer to 5 millimeters in diameter, and nanoplastics, which are even smaller, are found in virtually every environment on Earth, from mountain peaks to ...

Rising Prevalence of Chronic Diseases and Growing Number of Trauma and Injury Cases. Increasing Demand for Source Plasma From Biopharmaceutical Companies. Rising Demand for Blood Components and ...